FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis - 372 IPF Patients Enrolled -- Topline Data Anticipated Mid-2024 - SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient...

NextGen Prospect Has Launched a Strategic Partnership With PFF FAIRPORT, N.Y., Sept. 30, 2022 (GLOBE NEWSWIRE) -- NextGen Prospect, a cutting-edge sports data visualization and roster management solution, has partnered with PFF to provide stakeholders across...

NextGen Prospect Launches Strategic Partnership With PFF FAIRPORT, N.Y., Sept. 29, 2022 (GLOBE NEWSWIRE) -- NextGen Prospect, a cutting-edge sports data visualization and roster management solution, has partnered with PFF to provide stakeholders across...